The Relationship Between HER-2 Expression Levels and F-18-FDG PET/CT Parameters in Gastric Cancer

Erturk S. A., HASBEK Z., ÖZER H.

MOLECULAR IMAGING AND RADIONUCLIDE THERAPY, cilt.30, sa.3, ss.150-157, 2021 (ESCI) identifier identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 30 Sayı: 3
  • Basım Tarihi: 2021
  • Doi Numarası: 10.4274/mirt.galenos.2021.78055
  • Dergi Adı: MOLECULAR IMAGING AND RADIONUCLIDE THERAPY
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.150-157
  • Anahtar Kelimeler: Gastric cancer, PET/CT, HER-2, F-18-FDG, AMERICAN-PATHOLOGISTS, GUIDELINE, SOCIETY
  • Sivas Cumhuriyet Üniversitesi Adresli: Evet

Özet

Objectives: Human epidermal growth factor receptor-2 (HER-2) is a protooncogene encoded by ERBB2 on chromosome 17. (18)Fluoride-fluorodeoxyglucose positron emission tomography/computed tomography (F-18-FDG PET/CT) examination is frequently used to detect distant metastasis in gastric cancer imaging. This study aimed to investigate the relationship between the data obtained in the F-18-FDG PET/CT examination and HER-2 expression status in patients with gastric cancer.